Marc R Gastonguay

ACoP: The Tools, Carpenters, and Architects Building the Discipline of Pharmacometrics

Raymond Miller, Richard C Brundage, Marc Pfister, 2010, Journal of clinical pharmacology.

Missing Data in Model‐Based Pharmacometric Applications: Points to Consider

Daniel F Heitjan, Marc R Gastonguay, Jae Eun Ahn, 2010, Journal of clinical pharmacology.

Big Data: Challenges and opportunities for clinical pharmacology

Marc R Gastonguay, David Flockhart, Robert R Bies, 2016, British journal of clinical pharmacology.

MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges

Marc R Gastonguay, Daren Austin, Sandra A G Visser, 2020, Clinical pharmacology and therapeutics.

Population pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with type 2 diabetes

Marc R Gastonguay, Alexander Staab, Sreeraj Macha, 2013, Journal of clinical pharmacology.

Multiscale Physiology‐Based Modeling of Mineral Bone Disorder in Patients With Impaired Kidney Function

Marc R Gastonguay, M. Gastonguay, Matthew M Riggs, 2012, Journal of clinical pharmacology.

Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success

Marc R Gastonguay, Hartmut Derendorf, Klaus Romero, 2010, Journal of clinical pharmacology.

Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research Settings

Marc R Gastonguay, Jeffrey S Barrett, Michael J Fossler, 2008, Journal of clinical pharmacology.